Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
B
065170
vs
K
KOSPI 200
Over the past 12 months, BL PharmTech Corp has significantly outperformed KOSPI 200, delivering a return of +202% compared to KOSPI 200's +116% growth.
Stocks Performance
065170 vs KOSPI 200
Performance Gap
065170 vs KOSPI 200
Performance By Year
065170 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
BL PharmTech Corp
Glance View
BL PharmTech Corp is a South Korean drug maker. It develops, manufactures, and sells pharmaceutical products, including medicines used in hospitals and pharmacies, and it may also produce products for other healthcare companies under contract. Its business is built around making finished drug products rather than selling software or services. The company makes money mainly by selling its own medicines through wholesalers and healthcare channels, and by producing drugs for customers that need outside manufacturing. Its main customers are hospitals, clinics, pharmacies, distributors, and other pharmaceutical companies that buy finished products or contract manufacturing services. What makes the business model different is that it sits in the middle of the drug supply chain: it turns pharmaceutical ingredients and formulations into finished medicines that can be prescribed, stocked, and sold. That means its success depends on product approvals, manufacturing quality, and relationships with healthcare buyers more than on consumer branding or retail reach.